NALIRIFOX (5-fluorouracil, folinic acid [leucovorin], liposomal irinotecan, and oxaliplatin) is highly similar to FOLFIRINOX, but it employs liposomal
by A Hernández-Blanquisett 2024 Cited by 4PRODIGE 4/ACCORD 11: FOLFIRINOX vs. Gemcitabine Alone. FOLFIRINOX NALIRIFOX, and 387 were included in the control arm [19].
A systematic review and meta-analysis of randomized clinical trials comparing NALIRIFOX, FOLFIRINOX, and gemcitabine with nab-paclitaxel as first-line chemotherapy for metastatic pancreatic cancer. The results suggest that NALIRIFOX and FOLFIRINOX have similar efficacy and safety profiles, while gemcitabine with nab-paclitaxel is inferior.
Although these data support the use of NALIRIFOX over gemcitabine plus nab-paclitaxel, head-to-head comparisons of NALIRIFOX vs FOLFIRINOX in patients with pancreatic cancer have yet to be
by F Nichetti 2024 Cited by 12According to the remaining trials, there was no statistically significant difference in ORR for NALIRIFOX (41.8%) compared with FOLFIRINOX (31.6
by C Springfeld 2024oxaliplatin (NALIRIFOX) versus nab-paclitaxel. gemcitabine FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
by BG Smaglo 2024 Cited by 85-Fluorouracial triplet regimen (FOLFIRINOX or NALIRIFOX) as the preferred neoadjuvant regimen. FOLFIRINOX vs. gemcitabine. 31.6% vs
by J Xing 2024Prospective randomized trials comparing FOLFIRINOX (NALIRIFOX) and gemcitabine plus nab-paclitaxel chemotherapy in pancreatic ductal
NALIRIFOX is similar to FOLFIRINOX because it, too, includes the drugs leucovorin, fluorouracil, and oxaliplatin. However, NALIRIFOX includes liposomal
then vs than
accept vs expect
alright vs all right
its vs it's
there vs their
waist vs waste
your vs you're, you are